Overall, 395 patients (60% female; median (IQR) age = 45 (35 to 52) years, body mass index = 25.7 (23.2 to 29.4) kg/m2, ALT levels = 30 (23 to 42) IU/L, 3% with ALT ≥ 3 × ULN, 15% with GGT levels ≥3 × ULN and 32% with metabolic syndrome) were included. This evidence concerns the gene GPT and metabolic syndrome.